Aspiriant LLC’s iShares S&P Mid-Cap 400 Value ETF IJJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Hold
3,976
0.01% 221
2026
Q1
$527K Hold
3,976
0.02% 212
2025
Q4
$523K Hold
3,976
0.02% 207
2025
Q3
$516K Sell
3,976
-189
-5% -$24.2K 0.02% 194
2025
Q2
$515K Sell
4,165
-424
-9% -$49.9K 0.02% 192
2025
Q1
$549K Sell
4,589
-75
-2% -$9.39K 0.02% 180
2024
Q4
$583K Sell
4,664
-1
-0% -$128 0.02% 177
2024
Q3
$577K Sell
4,665
-500
-10% -$59.4K 0.02% 182
2024
Q2
$586K Hold
5,165
0.02% 178
2024
Q1
$611K Hold
5,165
0.03% 177
2023
Q4
$589K Hold
5,165
0.03% 178
2023
Q3
$521K Sell
5,165
-95
-2% -$10.2K 0.03% 175
2023
Q2
$564K Buy
5,260
+284
+6% +$28.9K 0.03% 171
2023
Q1
$511K Hold
4,976
0.03% 173
2022
Q4
$502K Hold
4,976
0.03% 177
2022
Q3
$449K Hold
4,976
0.02% 176
2022
Q2
$469K Sell
4,976
-46
-0.9% -$4.69K 0.02% 170
2022
Q1
$551K Buy
5,022
+1,440
+40% +$155K 0.03% 167
2021
Q4
$396K Buy
+3,582
New +$390K 0.02% 198

Other funds holding IJJ

Aspiriant LLC's IJJ Position: Q2 2026 in Review

Aspiriant LLC held its iShares S&P Mid-Cap 400 Value ETF (IJJ) position steady in Q2 2026 at 3,976 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #221.

Aspiriant LLC first reported a position in IJJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $611K in Q1 2024. 874 funds tracked by Wall St. Rank hold IJJ as of Q2 2026.

  • Aspiriant LLC held 3,976 shares of iShares S&P Mid-Cap 400 Value ETF worth $587K as of Q2 2026.
  • Aspiriant LLC left its iShares S&P Mid-Cap 400 Value ETF share count unchanged in Q2 2026.
  • iShares S&P Mid-Cap 400 Value ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #221 holding.
  • Aspiriant LLC first reported a position in iShares S&P Mid-Cap 400 Value ETF in Q4 2021 and has held it in 19 quarters since.
  • Aspiriant LLC's iShares S&P Mid-Cap 400 Value ETF position peaked at $611K in Q1 2024.
  • 874 funds tracked by Wall St. Rank held iShares S&P Mid-Cap 400 Value ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.